We proudly present the winner of our first Single Cellome™ SU10 Research Equipment Grant Program: The grant goes to Düsseldorf, close to our German office in Ratingen. It is awarded to PD Dr. med. Sajjad Muhammad at the Clinic for Neurosurgery University Hospital Düsseldorf. Dr. Serdar Alpdogan and Dr. Dilaware Khan from the research group of PD Dr. Muhammad will utilize SU10 and mainly be working on different aspects of the pathophysiology of intracranial aneurysms and SAH (aneurysmal subarachnoid hemorrhage) at the cellular level.
The SU10 Research Equipment Grant
They received a Single Cellome™ SU10 Unit to use for up to 6 months plus live training and ongoing technical support from our experts Dr. Erika Zernickel and Dr. David Sustr.
Research focus
The research group of PD Dr. med. Muhammad is primarily interested in cellular and molecular mechanisms leading to the development of neurovascular pathologies including intracranial aneurysms, subarachnoid hemorrhage, and brain AVMs.
Core projects are focused on the investigation of endothelial cells and interactions between the central nervous system and immune system to search for biomarkers to develop point-of-care diagnostics and find novel pharmacological targets to treat neurovascular diseases.
The goal of the research grant is to exploit the therapeutic potential of different drugs and clones, which will be delivered into different cells using the new Single Cellome™ SU10 Unit to treat intracranial aneurysms and aSAH.
The results will explore novel targets at the level of endothelial cells and innate immune cells and can evolve novel immune cell-based therapeutic options for intracranial aneurysm-carrying patients.
The results will explore novel targets at the level of endothelial cells and innate immune cells and can evolve novel immune cell-based therapeutic options for intracranial aneurysm-carrying patients.
We are wishing Dr. Alpdogan and Dr. Khan a lot of success with their research!
